Frequency, risk factors and features of hyperlactatemia in a large number of patients undergoing antiretroviral therapy
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (14) , 2131-2133
- https://doi.org/10.1097/00002030-200309260-00019
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Lactacidemia in Asymptomatic HIV-Infected Subjects Receiving Nucleoside Reverse-Transcriptase InhibitorsClinical Infectious Diseases, 2002
- Symptomatic Elevations of Lactic Acid and Their Response to Treatment Manipulation in Human Immunodeficiency Virus–Infected Persons: A Case SeriesClinical Infectious Diseases, 2001
- Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort StudyClinical Infectious Diseases, 2001
- Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitorsSexually Transmitted Infections, 2001
- The metabolic toxicities of antiretroviral therapyInternational Journal of STD & AIDS, 2001
- Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapyAIDS, 2001
- Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapyAIDS, 2001
- Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapyAIDS, 2000
- Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four CasesAnnals of Internal Medicine, 2000
- Lactic Acidosis in the Setting of Antiretroviral Therapy for the Acquired Immunodeficiency SyndromeAmerican Journal of Nephrology, 2000